FDA Nominee Overton Faces Senate Hearing

Dr. Heidi Overton, nominated to head the U.S. Food and Drug Administration, faced a Senate confirmation hearing where lawmakers questioned her on the president’s false statements about the measles vaccine and his involvement in tobacco policy.

During the session, senators asked Overton to clarify the accuracy of the president’s claims regarding vaccine safety and to explain her stance on tobacco regulation, highlighting concerns over public health messaging.

Overton defended the scientific consensus on measles vaccination and emphasized the importance of evidence‑based policy in both vaccine and tobacco regulation.